These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15016318)

  • 1. Rapid induction of skin and mammary tumors in human c-Ha-ras proto-oncogene transgenic rats by treatment with 7,12-dimethylbenz[a]anthracene followed by 12-O-tetradecanoylphorbol 13-acetate.
    Park CB; Fukamachi K; Takasuka N; Han BS; Kim CK; Hamaguchi T; Fujita K; Ueda S; Tsuda H
    Cancer Sci; 2004 Mar; 95(3):205-10. PubMed ID: 15016318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High susceptibility of transgenic rats carrying the human c-Ha-ras proto-oncogene to chemically-induced mammary carcinogenesis.
    Tsuda H; Asamoto M; Ochiya T; Toriyama-Baba H; Naito A; Ota T; Sekiya T; Terada M
    Mutat Res; 2001 Jun; 477(1-2):173-82. PubMed ID: 11376698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of c-Ha-ras gene mutations in skin tumors induced in carcinogenesis-susceptible and carcinogenesis-resistant mice by different two-stage protocols or tumor promoter alone.
    Pazzaglia S; Mancuso M; Primerano B; Rebessi S; Biozzi G; Covelli V; Saran A
    Mol Carcinog; 2001 Feb; 30(2):111-8. PubMed ID: 11241758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic rats carrying human c-Ha-ras proto-oncogene are highly susceptible to N-nitrosomethylbenzylamine induction of esophageal tumorigenesis.
    Asamoto M; Toriyama-Baba H; Ohnishi T; Naito A; Ota T; Ando A; Ochiya T; Tsuda H
    Jpn J Cancer Res; 2002 Jul; 93(7):744-51. PubMed ID: 12149139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic rats carrying human c-Ha-ras proto-oncogenes are highly susceptible to N-methyl-N-nitrosourea mammary carcinogenesis.
    Asamoto M; Ochiya T; Toriyama-Baba H; Ota T; Sekiya T; Terada M; Tsuda H
    Carcinogenesis; 2000 Feb; 21(2):243-9. PubMed ID: 10657964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis.
    Ota T; Asamoto M; Toriyama-Baba H; Yamamoto F; Matsuoka Y; Ochiya T; Sekiya T; Terada M; Akaza H; Tsuda H
    Carcinogenesis; 2000 Jul; 21(7):1391-6. PubMed ID: 10874018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid induction of skin tumors in human but not mouse c-Ha-ras proto-oncogene transgenic mice by chemical carcinogenesis.
    Muto S; Katsuki M; Horie S
    Cancer Sci; 2006 Sep; 97(9):842-7. PubMed ID: 16805855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
    Owens DM; Spalding JW; Tennant RW; Smart RC
    Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NTP Initiation/Promotion Study of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in Swiss (CD-1(R)) Mice (Mouse Skin Study).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1995 May; 444():1-136. PubMed ID: 12595919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation of early clonal expansion of two mutant 61st codon c-Ha-ras alleles in DMBA/TPA treated mouse skin by nested PCR/RFLP.
    Finch JS; Albino HE; Bowden GT
    Carcinogenesis; 1996 Dec; 17(12):2551-7. PubMed ID: 9006088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent mutation profile in the c-Ha-ras proto-oncogene of skin tumors in mice initiated with benzo[a]pyrene.
    Wei SJ; Chang RL; Merkler KA; Gwynne M; Cui XX; Murthy B; Huang MT; Xie JG; Lu YP; Lou YR; Jerina DM; Conney AH
    Carcinogenesis; 1999 Sep; 20(9):1689-96. PubMed ID: 10469612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metallothionein deficiency enhances skin carcinogenesis induced by 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate in metallothionein-null mice.
    Suzuki JS; Nishimura N; Zhang B; Nakatsuru Y; Kobayashi S; Satoh M; Tohyama C
    Carcinogenesis; 2003 Jun; 24(6):1123-32. PubMed ID: 12807749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting incidence of ras mutations in rat mammary and mouse skin tumors induced by anti-benzo[c]phenanthrene-3,4-diol-1,2-epoxide.
    Ronai ZA; Gradia S; el-Bayoumy K; Amin S; Hecht SS
    Carcinogenesis; 1994 Oct; 15(10):2113-6. PubMed ID: 7955041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-12 deficiency suppresses 12-O-tetradecanoylphorbol-13-acetate-induced skin tumor development in 7,12-dimethylbenz(a)anthracene-initiated mouse skin through inhibition of inflammation.
    Sharma SD; Meeran SM; Katiyar N; Tisdale GB; Yusuf N; Xu H; Elmets CA; Katiyar SK
    Carcinogenesis; 2009 Nov; 30(11):1970-7. PubMed ID: 19759192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-stage carcinogenesis in NMRI mice: intravaginal application of 7,12-dimethylbenz[a]anthracene as initiator followed by the phorbol ester 12-O-tetradecanoylphorbol-13-acetate as promoter.
    Goerttler K; Löhrke H; Hesse B
    Carcinogenesis; 1980 Aug; 1(8):707-13. PubMed ID: 11272124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential mammary carcinogenic effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in human c-Ha-ras proto-oncogene transgenic rats.
    Naito A; Suzuki A; Ueda S; Nomoto H; Toriyama-Baba H; Asamoto M; Tsuda H
    Cancer Sci; 2004 May; 95(5):399-403. PubMed ID: 15132766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 7,12-Dimethylbenz[a]anthracene/12-O-tetradecanoyl-phorbol-13-acetate-mediated skin tumor initiation and promotion in male Sprague-Dawley rats.
    Schweizer J; Loehrke H; Hesse B; Goerttler K
    Carcinogenesis; 1982; 3(7):785-9. PubMed ID: 6811148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide.
    Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A
    Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible enhancing effects of atrazine and nonylphenol on 7,12-dimethylbenz[a]anthracene-induced mammary tumor development in human c-Ha-ras proto-oncogene transgenic rats.
    Fukamachi K; Han BS; Kim CK; Takasuka N; Matsuoka Y; Matsuda E; Yamasaki T; Tsuda H
    Cancer Sci; 2004 May; 95(5):404-10. PubMed ID: 15132767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of Diethylphthalate (CAS No. 84-66-2) in F344/N Rats and B6C3F1 Mice (Dermal Studies) with Dermal Initiation/ Promotion Study of Diethylphthalate and Dimethylphthalate (CAS No. 131-11-3) in Male Swiss (CD-1(R)) Mice.
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1995 May; 429():1-286. PubMed ID: 12616302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.